BTOG - British Thoracic Oncology Group: Recent Episodes
btog
The British Thoracic Oncology Group (BTOG) is the multi-disciplinary group for healthcare professionals involved with thoracic malignancies throughout the UK.
BTOG's mission is to To support and educate thoracic oncology healthcare professionals, creating a professional community to exchange ideas, information and innovation and to foster the development of research. The overall aim is to represent the needs of people with thoracic malignancies in the UK and ensure they have equitable access to optimal care.
Find out more here - https://www.btog.org/
This first-in-a-series BTOG Webcast includes an introduction from Cecilia Pompili and then Allan Hackshaw looks at what training and support a patient advocate could be offered when they take part in the development of research proposals. The webcast concludes with a “fireside chat” with Sally Hall who is an established patient advocate. The role of a patient advocate in research is often referred to as PPI - PPI stands for Patient and Public Involvement.
In this BTOG podcast, Dr Tom Newsom-Davis, Chair of BTOG and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, is joined by Dr Joanne Evans, Consultant in Medical Oncology at Imperial College Healthcare NHS Trust, and Adam Januszewski, Consultant Medical Oncologist at St Bartholomew’s Hospital, to discuss key lung cancer highlights from ASCO 2026.
The panel reviews major data across advanced and early-stage lung cancer, including HARMONi-6, WUKONG-28, ALKOVE-1, OPTITROP-Lung05 and LORIN, as well as updates from CROWN, LIBRETTO-432, CHRYSALIS-2 and DELLphi-304.
Topics include emerging antibody-drug conjugates, targeted treatments for EGFR exon 20 insertions, ALK-positive disease, perioperative therapy, atypical EGFR mutations, RET-positive disease and CNS activity in small cell lung cancer.
The discussion considers what the data may mean for UK practice, where further global evidence is needed, and how efficacy, toxicity and patient selection should shape future treatment decisions.
In this BTOG webcast and podcast, Dr Clive Peedell is joined by Dr John Conibear and Rebecca Pickles to discuss key thoracic oncology highlights from ESTRO 2026.
The conversation covers single-fraction SABR for early-stage lung cancer, radiotherapy and immunotherapy sequencing, approaches for frailer patients with stage III disease, palliative and consolidative radiotherapy in stage IV disease, and the growing role of AI, adaptive radiotherapy and radiographer-led services.
The speakers reflect on what the latest data could mean for clinical practice, while also considering the practical realities of delivering high-quality radiotherapy in busy NHS departments.
BTOG Steering Committee Members, Tanya Patrick and Neal Navani have reviewed the new 9th Edition TNM Lung Cancer Classification and produced:
- Webcast running through TNM9 in detail
- A full presentation to accompany the webcast which you can use to present to your team
- A brief presentation highlighting what has changed which you can use to present to your team
BTOG is hoping to receive a stock of the laminated reference cards from IASLC to give out at BTOG events but in the meantime you can access PDF or buy online (free for IASLC members)
In this special BTOG podcast, we partner with the National Lung Cancer Audit (NLCA) to explore the latest State of the Nation data and what it means for lung cancer care across the UK.
Host Tom Newsom-Davis is joined by leading experts including John Conibear, Douglas West, Lauren Dixon, and Sarah Cook to unpack the trends shaping modern practice—from the rise in early-stage diagnosis and expanding surgical capacity, to the growing complexity of systemic therapies and the role of data in driving improvement.
The discussion highlights how routinely collected NHS data is transformed into actionable insight, revealing variation in care, identifying opportunities for improvement, and ultimately helping teams deliver better outcomes for patients.
Key themes include:
- The impact of lung cancer screening and earlier diagnosis
- Increasing surgical activity and evolving techniques
- Advances in systemic treatments and access challenges
- The importance of accurate data capture in MDTs
- How the NLCA is driving quality improvement across the NHS
This episode is essential listening for anyone involved in lung cancer care—offering practical insight into how data can be used to benchmark performance, reduce variation, and improve patient outcomes nationwide.
BTOG does Lung NETs:
Hosted by Dr Emma O'Dowd, Prof Matt Evison and Prof Was Mansoor explain why we should move beyond “carcinoid,” how diagnosis and staging pathways differ from standard lung cancer, and what is needed to improve access, follow-up, and treatment options.
Join BTOG and the UKLCC to discuss the recent UKLCC conference “UK Lung Cancer: 20 years on – what’s next?”
Participants:
- Dr Tom Newsom-Davis, Chair, BTOG Steering Committee and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London
- Dr Emma O’Dowd, BTOG Steering Committee Member and Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University
- Dr David Gilligan, UKLCC Chair and Consultant Clinical Oncologist at Cambridge University Hospitals & Royal Papworth Hospitals, Cambridge, UK and an Affiliated Assistant Professor at the University of Cambridge.
A look at the top 10 abstracts – the rationale and design, efficacy, side effects and potential impact with Dr Tom Newsom-Davis, Chair, BTOG and Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London; Dr Shobhit Baijal, BTOG Steering Committee Member and Consultant Medical Oncologist, University Hospital Birmingham NHS Trust, Birmingham and; Dr Sharmistha Ghosh, Associate Specialist Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London.
In this episode of the series, BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.
In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Dr Jason Adhikaree, Clinical Associate Professor in Oncology/Honorary Consultant in Medical Oncology, at Nottingham NHS Trust.
In this episode of the series, BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talk to Miss Sofina Begum, Consultant Thoracic Surgeon at Royal Brompton Hospital.
BTOG Steering Committee Chair, Dr Tom Newsom-Davis, Consultant Thoracic Medical Oncologist at Chelsea and Westminster Hospital, London and BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Dr Helen Liddicoat, Respiratory Physician from Dundee. Helen is Bronchoscopy Lead at her hospital and sits on the National Faculty for Advanced Bronchoscopy and Endobronchial Ultrasound at NHS Education Scotland.
Key highlights from the 2025 ASCO Annual Meeting, held in Chicago. Our expert panel review the most practice-changing presentations in thoracic oncology and discuss their potential impact on clinical care in the UK.
Topics include major advances in immunotherapy, precision medicine, radiotherapy trials, small cell lung cancer trials, liquid biopsy and supportive care — with a focus on what UK clinicians need to know. This is an excellent opportunity to catch up on key data and emerging trends from the world’s largest cancer conference.
BTOG Steering Committee member, Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham talks to Professor Sanjay Agrawal, Consultant in Respiratory & Intensive Care Medicine, University Hospitals of Leicester NHS Trust. Sanjay is also National Speciality Advisor for Tobacco Dependency at NHS England and Speciality Advisor on Tobacco at the Royal College of Physicians.
The National Lung Cancer Audit (NLCA), commissioned by the Healthcare Quality Improvement Partnership (HQIP), evaluates the care received by patients diagnosed with lung cancer in NHS hospitals within England and Wales. We aim to stimulate quality improvement activities and reduce variation in the care, treatment and outcomes of patients diagnosed with lung cancer.
Dr Tom Newsom-Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital and Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham were joined by Dr Riyaz Shah, Consultant Medical Oncologist at the Kent Oncology Centre to talk about the HER2 Mutation.
BTOG does … MET Podcast is now released – this is part 5 of a series looking at mutations in lung cancer – we have already looked at BRAF, KRAS, RET and ROS1.
Recorded recently, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect discussed MET with Dr Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology at University of Newcastle upon Tyne.
Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of both WCLC 2024 and ESMO 2024.
WCLC 2024 Highlights - Martin Forster, Consultant Medical Oncologist and Associate Professor, University College Hospital
ESMO 2024 Metastatic Disease Highlights - Meenali Chitnis, Consultant Medical Oncologist, Oxford Cancer & Haematology Centre
ESMO 2024 Early and Locally Advanced Disease Highlights - Yvonne Summers, Consultant in Medical Oncology, The Christie NHS Foundation Trust
Panel Discussion led by Chair
Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of ASCO 2024 held May 31 - June 4 in Chicago.
Broadcast live on Monday 17 June 2024 18.00-19.15
Targeted Therapies in Advanced Stage NSCLC Dr Louise Lim, Consultant Medical Oncologist, St Bartholomew's Hospital
Immunotherapy in Advanced Stage NSCLC Dr Tom Newsom-Davis, Consultant in Medical Oncology, Chelsea and Westminster Hospital
Locally Advanced NSCLC, Small Cell Carcinoma and Mesothelioma Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Panel Discussion led by Chair
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Chair Elect is joined for this podcast by clinical oncology colleagues, Professor Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology, University of Manchester and Honorary Consultant Clinical Oncologist, The Christie NHS Foundation Trust and Dr Fiona McDonald, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust.
Chaired by Neal Navani, NLCA Senior Clinical Lead and BTOG Steering Committee Member, this webinar presented the NLCA State of the Nation Report 2024.
Following on from Professor Eric Lim’s presentation “MARS2: results and UK implications” at BTOG 2024, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect, discusses Mesothelioma and Surgery with Professor Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital and Professor of Thoracic Surgery, Imperial College London and Mr David Waller, Consultant Thoracic Surgeon at Barts Health NHS Trust.
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Professor Najib M Rahman, Professor of Respiratory Medicine, Director, Oxford Respiratory Trials Unit and Nuffield Department of Medicine, University of Oxford
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Meenali Chitnis, Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust.
BTOG does ... RET – this is part 3 of a series looking at mutations in lung cancer – we have already looked at BRAF and KRAS. Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Nadza Tokaca, Consultant Medical Oncologist at the Royal Marsden Hospital.
Chaired by Professor Sanjay Popat, this webinar covered clinically impactful thoracic oncology highlights of ESMO 2023 held in Madrid.
The speakers are:
Dr Tom Newsom-Davis
Consultant in Medical Oncology, Chelsea and Westminster Hospital, London
Dr Riyaz Shah
Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
Dr Yvonne Summers
Consultant in Medical Oncology, The Christie NHS Foundation Trust
Originally live on Wednesday 8th November 2023, 18:00-19:10
The latest episode in our series of podcasts is out now. This episode features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talking with
- Dr Paul Beckett, Clinical Lead for Lung Cancer, Consultant Respiratory Physician at University Hospitals of Derby and Burton
- Victoria Anderson, Lung Cancer Nurse Specialist, Royal Victoria Infirmary
This webinar covers the clinically impactful thoracic oncology highlights of WCLC 2023 held 9th to 12th September 2023 in Singapore. Chaired by Professor Sanjay Popat, the speakers are:
MARS2 - John Edwards
Radical NSCLC - Gerry Hanna
Metastatic NSCLC and SCLC - Fiona Blackhall
Radiotherapy - Fiona McDonald
Original broadcast on 25th September 2023.
Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talking with Dr Colin Lindsay, Clinical Senior Lecturer (1) and Honorary Consultant (2) in Thoracic Medical Oncology
1 Division of Cancer Sciences, The University of Manchester
2 The Christie NHS Foundation Trust, Manchester
This episode features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talking with Professor Jarushka Naidoo, Consultant Medical Oncologist at Beaumont Hospital, Dublin and Professor, RCSI.
The latest in our podcast series is now available. This episode features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Dr Lianne Castle, Consultant Respiratory Physician at Barts Health NHS Trust talking with Dr Neal Navani, Lead Clinician for Lung Cancer Services at UCLH and Senior Clinical Lead of the UK National Lung Cancer Audit and Dr John Conibear, Consultant Clinical Oncologist at St. Bartholomew’s Hospital.
https://www.lungcanceraudit.org.uk/
https://www.lungcanceraudit.org.uk/reports/nlca-state-of-the-nation-report-2023/
This episode features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talking with Dr Shobit Baijal, Consultant Medical Oncologist from University Hospital Birmingham NHS Trust. Back in November 2021, BTOG released a Podcast on this same subject; there have been changes in this area and therefore an ideal time to review and repeat to see what the developments have been.
Features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Dr Lianne Castle, Consultant Respiratory Physician at Barts Health NHS Trust talking with Dr Zoe Merchant, AHP Clinical Lead for Prehab4Cancer, Greater Manchester
This episode features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Dr Lianne Castle, Consultant Respiratory Physician at Barts Health NHS Trust talking with Miss Henrietta Wilson, Consultant Adult Thoracic Surgeon at St Bartholomew’s Hospital.
BTOG Steering Committee Chair, Tom-Newsom Davis and Consultant Respiratory Physician, Leanne Castle talk to Consultant Clinical Oncologist, David Gilligan about thymic tumours.
Features Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Dr Lianne Castle, Consultant Respiratory Physician, Barts Health NHS Trust talking with Dr Debashis Sarker, Senior Lecturer and Consultant in Medical Oncology at King’s College London.
BTOG Steering Committee Vice Chair, Tom Newsom-Davis talks with Miss Sofina Begum, Consultant Thoracic Surgeon at the Royal Brompton Hospital, London.
BTOG Steering Committee Vice Chair, Tom Newsom-Davis talks with fellow BTOG Steering Committee Member, Dr Fiona McDonald, Consultant Thoracic Clinical Oncologist at the Royal Marsden NHS Foundation Trust. ESTRO is the European Society Radiation Oncology – ESTRO 2022 was held in May in Copenhagen.
BTOG Steering Committee Respiratory Trainee Representative, Dr Helen McDill talks with fellow Steering Committee member, Professor Sanjay Agrawal, Consultant Respiratory Intensivist at University Hospitals of Leicester NHS Trust.
BTOG Steering Committee Trainee Representatives, Dr Helen McDill, Respiratory Registrar in the South-West and Dr Adam Januszewski, now a Consultant Medical Oncologist (previously Higher Speciality Trainee in Medical Oncology) in London talk about what draw them into the thoracic oncology speciality and their experience of being a trainee and of course of their work on the BTOG steering committee.
You can now listen to the latest in our series of podcasts. This one features BTOG Steering Committee Member Dr Stephen Harrow, Consultant Clinical Oncologist Thoracic Malignancies, National Research Scotland Career Fellow at Edinburgh Cancer Centre and Honorary Clinical Associate Professor at Glasgow University talk with Dr David Woolf, Consultant Clinical Oncologist at the Christie NHS Foundation Trust about palliative thoracic radiotherapy.
BTOG Steering Committee Vice Chair, Dr Tom Newsom Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital, London talks with Karen Clayton, Macmillan Lung Cancer Lead Nurse, Macclesfield DGH, East Cheshire Trust and Committee Member of Lung Cancer Nursing UK
BTOG Steering Committee Respiratory Trainee Representative, Dr Helen McDill talks with Professor Nick Maskell, Professor of Respiratory Medicine at the University of Bristol (UoB) and Honorary Consultant Chest Physician at North Bristol NHS Trust.
BTOG Steering Committee Member, Dr Stephen Harrow, Consultant Clinical Oncologist, Honorary Clinical Associate Professor at Beatson West of Scotland Cancer Centre talks with Dr David Palma, Radiation Oncologist at the London Health Sciences Centre, Canada and Clinician-Scientist with the Ontario Institute for Cancer Research.
BTOG Steering Committee Vice Chair, Dr Tom Newsom Davis, Vice-Chair of the BTOG Steering Committee talks with Professor Sanjay Popat the Chair of the BTOG Steering Committee.
BTOG Steering Committee Vice Chair, Dr Tom Newsom Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital, London talks with Dr Angeles Montero, Cardiothoracic Consultant Histopathologist at Manchester University Hospital.
BTOG Steering Committee Respiratory Trainee Representative, Dr Helen McDill talks with Dr Emma O’Dowd, Consultant Respiratory Physician at Nottingham University Hospitals NHS Trust and member of NCRI Screening, Prevention and Early Diagnosis Group
BTOG Steering Committee Respiratory Trainee Representative, Dr Helen McDill talks with Dr Matthew Evison, Consultant Physician in Respiratory Medicine at the North West Lung Cancer & University of Manchester and Clinical Lead for the CURE Programme and Tobacco Addiction.
Live on Thursday 9th December, experts Mr Shobhit Baijal, Dr Joanne Evans and Dr Rafaelle Califano discuss immunotherapy in NSCLC, in SCLC and managing immunotherapy toxicities.
BTOG Steering Committee Vice Chair, Tom Newsom-Davis talks with Dr Neal Navani, Consultant/Associate Professor in Respiratory Medicine at University College London Hospital
BTOG Steering Committee Vice Chair Tom Newsom-Davis talks to Professor Samreen Ahmed, Consultant Medical Oncologist, University Hospitals of Leicester about EGFR mutated lung cancer.
Chaired by Tom Newsom-Davies with guest speakers on the following topics:
Pain: Interventional anaesthesia for thoracic malignancies – Rachael English, CNS Beatson West of Scotland Cancer Centre
Breathlessness: New developments – Professor Marie Fallon, University of Edinburgh
Cachexia – Barry Laird, Senior Clinical Lecturer in Palliative Medicine, University of Edinburgh
BTOG Steering Committee members, Dr Matt Evison and Dr Sanjay Agrawal, developed an interesting programme for this BTOG Masterclass: Leading your Lung Cancer Pathway.
BTOG experts bring you a whistle-stop tour of the relevant presentations from these two landmark conferences, with a focus on the research that might change practice in the UK. Approved for 1 category 1 (external) CPD credit from the Federation of the Royal Colleges of Physicians of the United Kingdom.
James Spicer chairs this BTOG Masterclass session where Alastair Greystoke will talk about adjuvant targeted therapies while Samreen Ahmed will talk about peri-operative immunotherapy.
BTOG Surgical Webinar – Controversies in the Management of Early-Stage Lung Cancer Thursday 25th March 2021
Biographies Kelvin Lau Consultant Thoracic Surgeon, London I am consultant and lead thoracic surgeon at St Bartholomew’s Hospital, London. I qualified from the University of Oxford in 2002. During my time at Oxford I was awarded a ICRF scholarship to investigate molecular angiogenesis and vascular targeting of anti-cancer treatment at the Institute of Molecular Medicine for which I was awarded a doctorate of philosophy. After my training, I obtained his membership in 2005, and was awarded the only cardiothoracic surgery national training number in 2006. I received my training in Glenfield Hospital, Nottingham and London, and went on to complete a minimally invasive thoracic surgery fellowship at the Chinese University of Hong Kong where I was then made honorary assistant professor.
On return to the UK in 2013, I was appointed as the first consultant thoracic surgeon for St Bartholomew’s Hospital where I set up the thoracic surgery service, introduced VATS lobectomy and endobronchial programmes, and recently, one of the first dedicated 24/7 cardiothoracic robotic surgery programme in the UK.
In November 2015, I led the first team in Europe to successfully use the latest version of navigation bronchoscopy and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018.
Robert Stevenson Consultant Clinical Oncologist, Birmingham Dr Stevenson qualified from the University of Warwick in 2005. He trained within the West Midlands and was appointed as Consultant Clinical Oncologist at University Hospitals Birmingham in 2014. Dr Stevenson is also a visiting consultant to Sandwell and West Birmingham Hospitals NHS Trust and Heart of England NHS trust. Dr Stevenson specialises in the treatment of lung and urological cancers with chemotherapy, hormonal therapy and radiotherapy.
Dr Stevenson is also involved in 4-dimensional and stereotactic lung radiotherapy within Birmingham and has experience in delivering Cyberknife treatment to an early stage of lung cancer.
Dr Stevenson has published papers in peer-reviewed journals and is the principal investigator (PI) for a number of national clinical trials.
Malcolm Will Consultant Thoracic Surgeon, The Royal Infirmary of Edinburgh. Specialist interest in minimally invasive thoracic surgery, airway diseases, chest wall disorders and interventions for COPD
BTOG Steering Committee members present an update on relevant data/research presented at WCLC 2020 (postponed from September 2020 to January 2021).
Welcome Tom Newsom-Davis Top Medical Oncology Abstracts Riyaz Shah Q&A Tom Newsom-Davis Top Clinical Oncology Abstracts Fiona McDonald Q&A Tom Newsom-Davis Top Respiratory Medicine Abstracts Richard Booton Q&A & Close Tom Newsom-Davis
Chair: Dr Tom Newsom-Davis – BTOG Steering Committee Vice-Chair Faculty: Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre; Dr Fiona McDonald, Consultant Clinical Oncologist, Royal Marsden Hospital; Professor Richard Booton, Clinical Director for Lung Cancer & Thoracic Surgery and Professor of Respiratory Medicine at Manchester University NHS Foundation Trust and University of Manchester.
Aims: to educate delegates on benefits of next generation sequencing (NGS) genotyping to identify rare variants for NHS-reimbursed therapies, compassionate use programmes and trials enrolment. All data will pertain to advanced NSCLC.
Chair: Professor Sanjay Popat 17:30 Introduction Sanjay Popat 17:31 BRAF, KRAS, & insertion mutations you need to know about Raffaele Califano 17:46 Splices and fusions you need to know about Alastair Greystoke 18:01 How will we find suitable patients? Rachel Butler 18:16 Q&A
18:30 Close
BTOG Masterclass on Stage III NSCLC
Approved by the Federation of the Royal Colleges of Physicians of the United Kingdom
Chair: Professor Sanjay Popat
Panel: Professor David Baldwin (Respiratory Medicine); Mr John Edwards (Surgery); Professor Samreen Ahmed (Medical Oncology); Professor Matthew Hatton (Clinical Oncology); Josie Roberts (Nursing); Dr Rhiannon Walters-Davies (Pharmacy)
Each panellist briefly summarises how practice has changed in their specialty and focus on moving forward with endemic COVID
Panel discussion & questions from webinar attendees.
Chair: Dr Tom Newsom-Davis – BTOG Steering Committee Vice-Chair
Faculty:
Dr Shobhit Baijal, Consultant Medical Oncologist, University Hospital Birmingham NHST
Dr David Gilligan, Consultant Oncologist and Associate Lecturer, University of Cambridge – Cambridge University Hospitals NHST
Professor James Spicer, Professor of Experimental Cancer Medicine and Consultant in Medical Oncology, King’s College London – Guy’s and St Thomas’ NHSFT
BTOG Steering Committee members will present an update on relevant data/research presented at ESMO 2020 on the topics below.
- Stage III NSCLC
- Small Cell Lung Cancer
- TKIs and Other Targeted Therapies
With Q&A after each presenter and at the end of whole session.
Exploring studies and advances in thoracic oncology showcased at the IASLC WCLC 2020 Virtual Presidential Symposium on 8th August and the potential implications on UK practice.
View on demand at btogwebinars.org Programme
Chair: Professor Sanjay Popat
The faculty will disseminate the trial data presented, discuss in UK context, and take questions.
ORIENT-11
Alastair Greystoke
Abstract 1: ORIENT-11: Sintilimab + Pemetrexed + Platinum as First-Line Therapy for Locally Advanced or Metastatic Non-Squamous NSCLC
(Speaker: Zhang Li, China)
eXalt3
Fiona Blackhall
Abstract 2: Phase 3 Randomized Study of Ensartinib vs Crizotinib in Anaplastic Lymphoma Kinase (ALK)–Positive NSCLC Patients: eXalt3
(Speaker: Leora Horn, USA)
CheckMate-743
Riyaz Shah
Abstract 3: First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
(Speaker: Paul Baas, Netherlands)
Faculty
Professor Sanjay Popat is Consultant Thoracic Medical Oncologist at the Royal Marsden Hospital and Professor of Thoracic Oncology at the Institute of Cancer Research and Chair of the BTOG Steering Committee
Dr Alastair Greystoke is Clinical Senior Lecturer and Honorary Consultant at the Newcastle University and the Northern Centre for Cancer Care
Professor Fiona Blackhall is Professor of Thoracic Oncology and Honorary Consultant in Medical Oncology at the Christie NHS Foundation Trust
Dr Riyaz Shah is a Consultant Medical Oncologist at Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust
In collaboration with Roy Castle Lung Cancer Foundation (RCLCF)
Approved for 1 CPD credit by the Federation of the Royal Colleges of Physicians of the United Kingdom (Ref: 131661) until July 2nd 2020.
BTOGASCO20
BTOG and RCLCF usually hold an annual in-person meeting to highlight the latest thoracic oncology treatment and research showcased at the annual ASCO meeting. For ASCO 2020, which is going ahead virtually, we are going to present a one hour webinar
Join BTOG Steering Committee members for an update on relevant data/research presented at ASCO 2020 on:
- advanced stage NSCLC: immunotherapy
- advanced stage NSCLC: targeted therapies
- locally advanced NSCLC
- SCLC and
- mesothelioma